BLCOBausch + Lomb Corporation

BLCO Stock Price, Valuation & Chart | Bausch + Lomb Corporation

Compare

$18.000+0.12 (+0.67%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Instruments & Supplies BLCO intrinsic value BLCO calculated fair value vs price

Overview Financials Dividends Ratios

BLCO Historical price chart

BLCO Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization6.43B

PE Ratio27.69

EPS0.65

Trading Volume355.79K

Today's High/Low18.46/17.86

Dividend Yield0.00

52 Week High/Low18.91/13.77

Shares Outstanding357.17M

BLCO Financial Statement

BLCO Analyst ratings

BLCO Analysis & performance metrics

BLCO Company profile

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and…

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care…

BLCO Management team

Name

Position

Osama A. EldessoukyCFO

Executive Vice President & Chief Financial Officer

Yehia Hashad M.D., Ph.D.

Executive Vice President of Research & Development and Chief Medical officer

Andrew J. Stewart

President of Global Pharmaceuticals & International Consumer

A. Robert D. Bailey

Executive Vice President & Chief Legal Officer

Frederick J. Munsch

Senior Vice President, Controller & Chief Accounting Officer

Jonathon L. Kellerman

Chief Compliance Officer

Brenton L. Saunders J.D.CEO

Chief Executive Officer & Chairman

Alan Waterhouse CPFA, MBA

Executive Vice President and Chief Supply Chain & Operations Officer

Name

Position

Osama A. EldessoukyCFO

Executive Vice President & Chief Financial Officer

Yehia Hashad M.D., Ph.D.

Executive Vice President of Research & Development and Chief Medical officer

Andrew J. Stewart

President of Global Pharmaceuticals & International Consumer

A. Robert D. Bailey

Executive Vice President & Chief Legal Officer

Frederick J. Munsch

Senior Vice President, Controller & Chief Accounting Officer

Jonathon L. Kellerman

Chief Compliance Officer

Brenton L. Saunders J.D.CEO

Chief Executive Officer & Chairman

Alan Waterhouse CPFA, MBA

Executive Vice President and Chief Supply Chain & Operations Officer

Management Team

Osama A. EldessoukyCFO

Executive Vice President & Chief Financial Officer

Yehia Hashad M.D., Ph.D.

Executive Vice President of Research & Development and Chief Medical officer

Andrew J. Stewart

President of Global Pharmaceuticals & International Consumer

A. Robert D. Bailey

Executive Vice President & Chief Legal Officer

Frederick J. Munsch

Senior Vice President, Controller & Chief Accounting Officer

Jonathon L. Kellerman

Chief Compliance Officer

Brenton L. Saunders J.D.CEO

Chief Executive Officer & Chairman

Alan Waterhouse CPFA, MBA

Executive Vice President and Chief Supply Chain & Operations Officer

Management

Osama A. EldessoukyCFO

Executive Vice President & Chief Financial Officer

Yehia Hashad M.D., Ph.D.

Executive Vice President of Research & Development and Chief Medical officer

Andrew J. Stewart

President of Global Pharmaceuticals & International Consumer

A. Robert D. Bailey

Executive Vice President & Chief Legal Officer

Frederick J. Munsch

Senior Vice President, Controller & Chief Accounting Officer

Jonathon L. Kellerman

Chief Compliance Officer

Brenton L. Saunders J.D.CEO

Chief Executive Officer & Chairman

Alan Waterhouse CPFA, MBA

Executive Vice President and Chief Supply Chain & Operations Officer

Total 8 executives

BLCO Frequently asked questions

What is Bausch + Lomb Corporation (BLCO) Stock Price?

Current stock price of Bausch + Lomb Corporation (BLCO) stock is $18.000. The stock price is +0.67% higher in the session. The intraday range can be seen from this page. Volume of Bausch + Lomb Corporation (BLCO) stock is 355.79K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Bausch + Lomb Corporation (BLCO) stock price going up or down today?

The stock price of Bausch + Lomb Corporation (BLCO) can change with earnings, company news, and overall market sentiment. Bausch + Lomb Corporation operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Bausch + Lomb Corporation stock expensive at its current price?

Whether Bausch + Lomb Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BLCO on this page is 27.69. EPS on this page is 0.65. Compare those figures with peers and growth expectations before deciding if the current Bausch + Lomb Corporation price is justified.

How has the stock price of Bausch + Lomb Corporation (BLCO) performed historically?

Historical performance for Bausch + Lomb Corporation (BLCO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BLCO reacted to past earnings and market events.

Should I buy Bausch + Lomb Corporation (BLCO) stock, at this price?

Buying Bausch + Lomb Corporation (BLCO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.